Harvard Bioscience Names CFO

Harvard Bioscience Inc. has named Michael Rossi as chief financial officer (CFO), effective immediately.  Rossi most recently served as CFO of Laborie Medical Technologies, a global medical devices company.

Jim Green, chairman, president and CEO stated, “Mike Rossi’s deep experience in finance, public company accounting, global business operations, and restructuring make him the perfect leader to partner with me to rapidly improve Harvard Bioscience’s financial and operating performance.”

Rossi, 45, brings to Harvard Bioscience more than 19 years of finance and operational expertise. Prior to serving as CFO of Laborie Medical Technologies, he served as CFO of Medical Specialties Distributors, a healthcare supply chain management solutions company for over three years. Prior to that role, Rossi held finance roles of increasing responsibility at various public companies, including Haemonetics Corporation, The Princeton Review Inc., American Tower Corporation, Sonus Networks and Manufacturers’ Services Limited. He began his professional career as an accountant at PricewaterhouseCoopers.

Rossi earned a bachelor of science degree in accounting, cum laude, from Babson College and an MBA, cum laude, from Babson College’s Olin School of Management.

Rossi said, “I am honored to join Harvard Bioscience and work with Jim and the company’s talented finance team to execute with urgency and quickly earn the trust of our shareholders.”

Harvard Bioscience is a global developer, manufacturer, and marketer of a broad range of solutions to advance life science. Its products are sold to thousands of researchers in over 100 countries through our global sales organization, websites, catalogs, and through distributors. The company has sales and manufacturing operations in the United States, the United Kingdom, Germany, Sweden, Spain, France, Canada, and China. – MPO